Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Applied Therapeutics, Inc.

CIK 1697532Updated Nov 16, 2026

Securities
Historical securities (1)APLT · NASDAQ · equity · closed Feb 3, 2026
Name history
Applied Therapeutics Inc. · through Mar 11, 2024

APLT price & chart

Provider market data
Historical security

This listing closed Feb 3, 2026. Live provider charts are shown only for current listings.

About the company

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. The Company’s lead drug candidate, govorestat, is a novel central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including Classic Galactosemia, Charcot-Marie-Tooth Sorbitol Dehydrogenase Deficiency (CMT-SORD) and phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG).

8-K · 2025-12-12 · 0001193125-25-316607

Company description from the cited filing.

Financials

FY 2024 · USD
Revenue455,000USD · FY 2024
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

Net income-105,624,000USD · FY 2024
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

Operating income-104,299,000USD · FY 2024
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

Diluted EPS-0.76USD per share · FY 2024
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q3 2023Q2 2025Q2 2024Q2 2023Q1 2025Q1 2024FY 2024FY 2023FY 2022FY 2021
ASSETS
AssetsUSD34,374,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

106,566,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

45,195,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

37,342,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

127,778,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

43,646,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

56,907,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

151,234,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

86,691,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

54,833,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

38,363,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

89,892,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD11,945,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

98,867,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

37,457,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

30,421,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

122,197,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

35,616,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

50,762,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

146,484,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

79,398,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

49,898,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

16,657,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

53,888,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Assets, CurrentUSD31,654,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

104,603,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

44,488,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

34,511,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

127,572,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

42,821,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

53,966,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

150,906,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

83,646,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

54,386,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

37,308,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

88,394,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Prepaid Expense and Other Assets, CurrentUSD19,709,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

5,483,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

7,031,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

4,090,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

5,122,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

7,205,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

3,204,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

4,169,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

4,248,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

4,234,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

6,728,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

7,571,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Operating Lease, Right-of-Use AssetUSD2,468,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

1,963,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

510,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

2,579,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

206,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

628,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

2,688,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

328,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

2,792,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

447,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

857,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

1,298,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD34,935,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

100,674,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

56,239,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

19,904,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

55,386,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

47,980,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

20,239,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

83,940,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

29,685,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

71,979,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

34,302,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

27,353,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD————————0
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

———
Common Stock, Value, IssuedUSD35,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

11,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

7,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

35,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

11,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

6,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

35,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

11,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

35,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

8,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

5,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

3,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Additional Paid in CapitalUSD635,759,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

624,098,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

419,856,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

634,768,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

622,007,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

384,197,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

632,668,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

619,807,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

631,181,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

451,432,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

352,828,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

328,958,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Retained Earnings (Accumulated Deficit)USD-636,355,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

-618,217,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

-430,907,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

-617,365,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

-549,626,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

-388,537,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

-596,035,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

-552,524,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

-574,210,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

-468,586,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

-348,823,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

-266,315,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD——————————51,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

-107,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Stockholders' Equity Attributable to ParentUSD-561,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

5,892,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2024-09-30

-11,044,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2023-09-30

17,438,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

72,392,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2024-06-30

-4,334,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2023-06-30

36,668,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

67,294,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2024-03-31

57,006,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

-17,146,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

4,061,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

62,539,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Liabilities and EquityUSD34,374,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

106,566,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

45,195,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

37,342,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

127,778,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

43,646,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

56,907,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

151,234,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

86,691,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

54,833,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

38,363,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

89,892,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Current liabilities:
Liabilities, CurrentUSD32,902,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

98,967,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

55,504,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

17,749,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

55,356,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

47,188,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

17,965,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

83,905,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

27,296,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

71,182,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

33,424,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

26,462,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Operating Lease, Liability, CurrentUSD467,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

264,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

491,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

447,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

185,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

486,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

426,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

308,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

406,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

429,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

477,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

442,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Accounts Payable, CurrentUSD4,800,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

2,837,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

6,005,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

4,861,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

2,683,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

4,687,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

4,868,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

4,019,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

4,433,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

1,742,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

4,534,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

9,461,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Operating Lease, Liability, NoncurrentUSD2,033,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

1,707,000
Source

10-Q · 2024-11-07 · 0000950170-24-122804

As of 2024-09-30

44,000
Source

10-Q · 2023-11-09 · 0001558370-23-018422

As of 2023-09-30

2,155,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

30,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

As of 2024-06-30

170,000
Source

10-Q · 2023-08-10 · 0001558370-23-014406

As of 2023-06-30

2,274,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

35,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

As of 2024-03-31

2,389,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

38,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

414,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

891,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Additional Financial Items
Cash, Cash Equivalents, and Short-term InvestmentsUSD——————————30,600,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

80,800,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Short-term InvestmentsUSD——————————13,923,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

26,935,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2024Q4 2023Q3 2025Q3 2024Q2 2025Q2 2024Q1 2025Q1 2024FY 2024FY 2023FY 2022FY 2021
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-21,825,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-83,938,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

-105,624,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-119,763,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-82,508,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-105,584,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——————1,487,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

2,379,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

13,467,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

7,360,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

9,162,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

11,177,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————435,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

527,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

2,691,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-2,792,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-4,927,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

8,821,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Deferred Income Tax Expense (Benefit)USD—————————0
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

0
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-28,636,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-18,911,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

-84,305,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-55,173,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-78,093,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-90,728,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————0
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

——13,872,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

13,170,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

12,433,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————0
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

115,497,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

113,805,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

74,542,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

27,692,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

74,717,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-28,636,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

96,586,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

29,500,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

33,241,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-37,231,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-3,578,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——11,945,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2025-09-30

98,867,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

As of 2024-09-30

30,421,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2025-06-30

122,197,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

As of 2024-06-30

50,762,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2025-03-31

146,484,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

As of 2024-03-31

79,398,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

As of 2024-12-31

49,898,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

As of 2023-12-31

16,657,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

53,888,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——1,141,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

2,091,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

2,100,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

1,890,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

1,487,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

2,379,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

15,567,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

7,360,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

9,162,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

11,177,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD——————————30,600,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

As of 2022-12-31

80,800,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

As of 2021-12-31

General and Administrative ExpenseUSD——8,157,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

15,037,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

13,175,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

10,580,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

17,688,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

9,066,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

56,010,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

20,623,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

27,316,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

43,048,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Marketable Securities, Unrealized Gain (Loss)USD—————————-51,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

158,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

5,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Net Income (Loss) Attributable to ParentUSD——-18,990,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-68,591,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

-21,330,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

2,898,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

-21,825,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-83,938,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

-105,624,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-119,763,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-82,508,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-105,584,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD—————2,898,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

2024-04-01 to 2024-06-30

—-83,938,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

—-119,763,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-82,508,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-105,584,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Nonoperating Income (Expense)USD——-2,232,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-38,848,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

1,768,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

23,338,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

3,700,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-62,845,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

-1,325,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-55,228,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

442,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

34,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Operating ExpensesUSD——17,758,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

29,865,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

23,098,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

20,584,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

25,525,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

21,283,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

104,754,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

74,528,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

82,950,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

105,618,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Other Nonoperating Income (Expense)USD——-7,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-21,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

-33,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

-34,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

-25,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-26,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

-77,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-27,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-177,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-521,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD—————————8,928,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

77,388,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

128,484,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Proceeds from Stock Options ExercisedUSD——————0
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

33,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

343,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

90,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

49,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

511,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2024Q4 2023Q3 2025Q3 2024Q2 2025Q2 2024Q1 2025Q1 2024FY 2024FY 2023FY 2022FY 2021
Total RevenueUSD——1,000,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

122,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

0
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

144,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

0
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

190,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

455,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

9,993,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

——
Operating Income (Loss)USD——-16,758,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-29,743,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

-23,098,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

-20,440,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

-25,525,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-21,093,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

-104,299,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-64,535,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-82,950,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-105,618,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Other Nonoperating Income (Expense)USD——-7,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-21,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

-33,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

-34,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

-25,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-26,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

-77,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-27,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-177,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-521,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Net Income (Loss) Attributable to ParentUSD——-18,990,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-68,591,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

-21,330,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

2,898,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

-21,825,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-83,938,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

-105,624,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-119,763,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-82,508,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-105,584,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Earnings Per Share, BasicUSD per share——-0.13
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-0.48
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

-0.15
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

0.02
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

-0.15
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-0.67
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

-0.76
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-1.42
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-2.18
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-4.12
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Earnings Per Share, DilutedUSD per share——-0.13
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-0.48
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

-0.15
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

-0.13
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

-0.15
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-0.67
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

-0.76
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-1.42
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-2.18
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-4.12
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Weighted Average Number of Shares Outstanding, Basicshares——145,559,604
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

144,345,781
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

145,091,474
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

143,934,239
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

144,787,971
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

125,318,993
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

139,534,746
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

84,244,494
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

37,825,431
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

25,598,181
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——145,559,604
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

144,345,781
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

145,091,474
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

152,392,748
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

144,787,971
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

125,318,993
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2024-01-01 to 2024-03-31

139,534,746
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

84,244,494
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

37,825,431
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

25,598,181
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Additional Financial Items
Current Income Tax Expense (Benefit)USD—————————0
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

0
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

General and Administrative ExpenseUSD——8,157,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

15,037,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

13,175,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

10,580,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

17,688,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

9,066,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

56,010,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

20,623,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

27,316,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

43,048,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Interest Income (Expense), Nonoperating, NetUSD——144,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

1,357,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

364,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

628,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

621,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

586,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

3,534,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

1,372,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

685,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

555,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD—————2,898,000
Source

10-Q · 2024-08-07 · 0001558370-24-011200

2024-04-01 to 2024-06-30

—-83,938,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

—-119,763,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

-82,508,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

-105,584,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Nonoperating Income (Expense)USD——-2,232,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

-38,848,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

1,768,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

23,338,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

3,700,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

-62,845,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

-1,325,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

-55,228,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

442,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

34,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Operating ExpensesUSD——17,758,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

29,865,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

23,098,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

20,584,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

25,525,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

21,283,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

104,754,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

74,528,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

82,950,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

105,618,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Research and Development ExpenseUSD——9,601,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2025-07-01 to 2025-09-30

14,828,000
Source

10-Q · 2025-11-13 · 0001193125-25-278818

2024-07-01 to 2024-09-30

9,923,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2025-04-01 to 2025-06-30

10,004,000
Source

10-Q · 2025-08-13 · 0000950170-25-108172

2024-04-01 to 2024-06-30

7,837,000
Source

10-Q · 2025-05-14 · 0000950170-25-070557

2025-01-01 to 2025-03-31

12,217,000
Source

10-Q · 2024-05-09 · 0001558370-24-007465

2024-01-01 to 2024-03-31

48,744,000
Source

10-K · 2025-04-15 · 0000950170-25-053840

2024-01-01 to 2024-12-31

53,905,000
Source

10-K · 2024-03-06 · 0001558370-24-002541

2023-01-01 to 2023-12-31

55,634,000
Source

10-K · 2023-03-23 · 0001558370-23-004398

2022-01-01 to 2022-12-31

62,570,000
Source

10-K · 2022-03-10 · 0001558370-22-003206

2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-271887

POS AM · 2026-02-03 · 0001193125-26-035528

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-278182

POS AM · 2026-02-03 · 0001193125-26-035517

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

d41524dex991.htm · 8-K · 2025-12-12

EX-99.1 5 d41524dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 December 11, 2025 For Release: Immediately Cycle Pharmaceuticals to Acquire Applied Therapeutics Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases NEW YORK, Dec. 11, 2025 - Applied Therapeutics, Inc. (Nasdaq: APLT; “Applied”), a clinical-stage biopharmaceutical company dedicated to creating transformative tr…

8-K · 2025-12-12 · 0001193125-25-316607

Read attachment ↗
aplt-ex99_1.htm · 8-K · 2025-11-20

EX-99.1 2 aplt-ex99_1.htm EX-99.1 EX-99.1 Applied Therapeutics Announces Corporate Updates NEW YORK, November 20, 2025 - Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that Applied Therapeutics’ Board of Directors (the “Board”) has initiated a process to explore strategic alternatives for the Company. The Board intends to evaluate a broad range of oppor…

8-K · 2025-11-20 · 0001193125-25-288900

Read attachment ↗
aplt-ex99_1.htm · 8-K · 2025-11-13

EX-99.1 2 aplt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Applied Therapeutics Reports Third Quarter 2025 Financial Results - Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes - Meeting scheduled with the FDA in 4Q 2025 to discuss govorestat for the treatment of Classic Galactosemia - New data on govorestat for the treatment of PMM2-CDG published in JIMD and presented at the 2025 ASHG Annual Meeting - Announces Board of …

8-K · 2025-11-13 · 0001193125-25-278814

Read attachment ↗
aplt-ex99_1.htm · 8-K · 2025-08-13

EX-99.1 2 aplt-ex99_1.htm EX-99.1 EX-99.1 Applied Therapeutics Reports Second Quarter 2025 Financial Results - CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT-SORD at PNS 2025 Annual Meeting highlighting slowed progression of disease observed via MRI at 24 months - Launched new sponsore…

8-K · 2025-08-13 · 0000950170-25-108169

Read attachment ↗
aplt-ex99_1.htm · 8-K · 2025-06-17

EX-99.1 2 aplt-ex99_1.htm EX-99.1 EX-99.1 Applied Therapeutics Inc. 545 Fifth Avenue, Suite 1400 New York, NY 10017 212.220.9319 www.appliedtherapeutics.com CONFIDENTIAL June 13, 2025 Riccardo Perfetti Dear Riccardo: This letter agreement (this “Agreement”) confirms our agreement regarding the terms of your separation from employment with Applied Therapeutics, Inc. (the “Company”). The Company and you are hereinafter referred to together as the “Parties” and each as a…

8-K · 2025-06-17 · 0000950170-25-087352

Read attachment ↗
aplt-ex99_2.htm · 8-K · 2025-06-17

EX-99.2 3 aplt-ex99_2.htm EX-99.2 EX-99.2 APPLIED THERAPEUTICS INC. Evan Bailey, MD June 13, 2025 Dear Evan: This Amended and Restated Offer Letter (the “Letter Agreement”) confirms the terms and conditions of your employment at Applied Therapeutics Inc. (the “Company”) effective June 15, 2025 (the “Effective Date”). This Letter Agreement amends, restates, and supersedes the offer letter between you and the Company signed on March 15, 2021 (the “Prior Offer Letter”). With those understa…

8-K · 2025-06-17 · 0000950170-25-087352

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.